|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.25 TWD | +1.79% |
|
-.--% | - |
| 27/04 | UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 12/08/25 | UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 1.68B 51.94M 45.39M 41.89M 38.61M 72.77M 5B 74.39M 501M 197M 2.45B 195M 191M 8.43B | P/E 2024 |
-9.63x | P/E 2025 | -5.68x |
|---|---|---|---|---|---|
| Enterprise Value | 1.97B 60.86M 53.18M 49.07M 45.23M 85.26M 5.86B 87.15M 587M 231M 2.87B 229M 224M 9.88B | EV / Sales 2024 |
3.58x | EV / Sales 2025 | 3.83x |
| Free-Float |
27.79% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.79% |
| 3 years | 10 |  | 38.5 |
| 5 years | 10 | | 202.59 |
| 10 years | 8.34 | | 288.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jung Kuang Yang
CEO | Chief Executive Officer | - | - |
Meng Han Hsu
DFI | Director of Finance/CFO | - | 11/04/2016 |
Ying Yun Fan
ADM | Chief Administrative Officer | - | 01/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Yun Fan
BRD | Director/Board Member | - | 30/06/2020 |
Yan Ning Kuo
BRD | Director/Board Member | - | 30/06/2020 |
Yao Hui Wei
BRD | Director/Board Member | - | 30/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.79% | -.--% | -.--% | -57.08% | 51.94M | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | |
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | |
| Average | +0.07% | +0.93% | +25.32% | +44.53% | 357.51B | |
| Weighted average by Cap. | +0.22% | +0.02% | +37.75% | +81.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 539M 16.63M 14.53M 13.41M 12.36M 23.3M 1.6B 23.81M 160M 63.04M 784M 62.44M 61.07M 2.7B | 514M 15.87M 13.87M 12.8M 11.8M 22.24M 1.53B 22.73M 153M 60.18M 749M 59.62M 58.31M 2.58B |
| Net income | -175M -5.39M -4.71M -4.34M -4M -7.54M -519M -7.71M -51.91M -20.42M -254M -20.22M -19.78M -874M | -296M -9.14M -7.99M -7.37M -6.8M -12.81M -880M -13.09M -88.12M -34.66M -431M -34.34M -33.58M -1.48B |
| Net Debt | 246M 7.6M 6.64M 6.13M 5.65M 10.65M 732M 10.89M 73.27M 28.82M 359M 28.55M 27.92M 1.23B | 289M 8.91M 7.79M 7.19M 6.63M 12.49M 859M 12.77M 85.93M 33.8M 420M 33.48M 32.74M 1.45B |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- 6562 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
